Oxidation of Low-Density Lipoprotein by Human Monocyte-Macrophages Results in Toxicity to the Oxidising Culture

References

• Tejada C., Strong J. P., Montenegro M. R., Restrepo C., Solberg L. A. Distribution of coronary and aortic atherosclerosis by geographic location, race and sex. Laboratory Investigation 1968; 18: 509–26
   PubMed Web of Science ®Google Scholar
• McGill H.C., Jr. Questions about the natural history of human atherosclerosis. Pathobiology of the Human Atherosclerotic Plaque, S Glagov, WP Newman, III, S.A. Schaffer. Springer-Verlag, NY 1990; 1–11
   Google Scholar
• Ball R. Y., Stowers E. C., Burton J. H., Cary N. R.B., Skepper J. N., Mitchinson M. J. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 1995; 114: 45–54
   PubMed Web of Science ®Google Scholar
• Mitchinson M. J. Macrophages, oxidised lipids and atherosclerosis. Medical Hypotheses 1983; 12: 171–178
   PubMed Web of Science ®Google Scholar
• Chisolm G. M., Hessler J. R., Morel D. W., Lewis L. J. In vitro autooxidation renders low density lipoprotein toxic to cells in culture. Arteriosclerosis 1981; 1: 359a
   Google Scholar
• Morel D. W., DiCorleto P. E., Chisolm G. M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. Journal of Lipid Research 1983; 24: 1070–1076
   PubMed Web of Science ®Google Scholar
• Cathcart M. K., Morel D. W., Chisolm G. M. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. Journal of Leukocyte Biology 1985; 38: 34–350
   Google Scholar
• Reid V. C., Mitchinson M. J. Toxicity of oxidised low-density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 1993; 98: 17–24
   PubMed Web of Science ®Google Scholar
• Reid V. C., Mitchinson M. J., Skepper J. N. Cytotoxicity of oxidised low density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. Journal of Pathology 1993; 171: 321–328
   Google Scholar
• Reid V. C., Hardwick S. J., Mitchinson M. J. Fragmentation of DNA in P388D1 macrophages exposed to oxidised low density lipoprotein. FEBS Letters 1993; 332: 218–220
   PubMedGoogle Scholar
• Gotoh N., Graham A., Niki E., Darley-Usmar V. M. Inhibition of glutathione synthesis increases the toxicity of oxidised low-density lipoprotein to human monocytes and macrophages. Biochemical Journal 1993; 296: 151–154
   PubMed Web of Science ®Google Scholar
• Marchant C. E., Law N. S., van der Veen C., Hardwick S. J., Carpenter K. L.H., Mitchinson M. J. Oxidized low density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants. FEBS Letters 1995; 358: 175–178
   PubMed Web of Science ®Google Scholar
• Leake D. S., Rankm S. M. The oxidative modification of low density lipoprotein by macrophages in vitro. Biochemical Journal 1990; 270: 741–748
   PubMed Web of Science ®Google Scholar
• Havel J., Eder H. A., Bragdon J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investination 1955; 34: 1345–1353
   PubMed Web of Science ®Google Scholar
• Carpenter K.L.H., Ballantine J. A., Fussell S., Enright J. H., Mitchinson M. J. Oxidation of cholesteryl lino-leate by human monocyte-macrophages in vitro. Atherosclerosis 1990; 83: 217–229
   PubMed Web of Science ®Google Scholar
• Carpenter K. L.H., Wilkins G. M., Fussell B., Ballantine J. A., Taylor S. E., Mitchinson M. J., Leake D. S. Production of oxidized lipids during modification of low density lipoprotein by macrophages or copper. Biochemical Journal 1994; 304: 625–633
   PubMed Web of Science ®Google Scholar
• Reid V. C., Brabbs C. E., Mitchinson M. J. Cellular damage in mouse peritoneal macrophages exposed to cholesteryl linoleate. Atherosclerosis 1992; 92: 251–260
   PubMed Web of Science ®Google Scholar
• Parthasarathy S., Young S. G., Witztum J. L., Pittman R. C., Steinberg D. J. Probucol inhibits oxidative modification of low density lipoprotein. Journal of Clinical Investigation 1986; 77: 641–644
   PubMed Web of Science ®Google Scholar
• Jialal I., Grundy S. M. Preservation of the endogenous antioxidants in low density lipoprotein by ascorb-ate but not probucol during oxidative modification. Journal of Clinical Investigation 1991; 87: 597–601
   PubMed Web of Science ®Google Scholar
• The alpha-tocopherol, beta carotene cancer prevention study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine 1994; 330: 1029–1035
   PubMed Web of Science ®Google Scholar
• Stubberfield C. R., Cohen G. M. Pyridine nucleo-tide changes in hepatocytes exposed to quinones. Free Radical Research Communications 1990; 8: 355–363
   Google Scholar
• Sun Y. P., Cotgreave LA., Lindeke B., Moldeus P. The protective effect of sulfite on menadione and diquat-induced cytotoxicity in isolated rat hepatocytes. Toxicology 1990; 66: 393–398
   Google Scholar
• Hardwick S. J., Wilson J. W., Fawthrop D. J., Boobis A. R., Davies D. S. Paracetamol toxicity in hamster isolated hepatocytes: the increase in cytosolic calcium accompanies, rather than precedes, loss of viability. Archives of Toxicology 1992; 66: 408–412
   PubMed Web of Science ®Google Scholar
• Smith E. B., Evans P. H., Downham M. D. Lipid in the aortic intima. The correlation of morphological and chemical characteristics. Journal of Atherosclerosis Research 1967; 7: 171–186
   PubMedGoogle Scholar
• Carpenter K. L.H., Taylor S. E., van der Veen C., Williamson B. K., Ballantine J. A., Mitchinson M. J. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochimica Biophysica Acta 1995; 1256(1995)141–150
   Google Scholar
• Ball R. Y., Carpenter K. L.H., Mitchinson M. J. What is the significance of ceroid in human atherosclerosis?. Archives of Pathology and Laboratoy Medicine 1987; 111: 1134–1140
   PubMed Web of Science ®Google Scholar
• Mitchinson M. J., Carpenter K. L.H., Hunt J. V., Marchant C. E., Reid V. C. Ceroid, macrophages and atherosclerosis. Oxidative Stress, Lipoproteins and Cardiovascular Dysfunction, C.A. Rice-Evans, K.R. Bruckdorfer. Portland Press, London 1995; 131–142
   Google Scholar
• Yla-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxida-tively modified LDL in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation 1989; 84: 1086–1095
   PubMed Web of Science ®Google Scholar
• Parums D. V., Brown D. L., Mitchinson M. J. Serum antibodies to oxidised low density lipoprotein and ceroid in chronic periaortitis. Archives of Pathology and Laboratory Medicine 1990; 114: 383–387
   PubMed Web of Science ®Google Scholar
• Heinecke J. W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. Journal of Clinical Investigation 1984; 74: 1890–1894
   PubMed Web of Science ®Google Scholar
• Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid per-oxidation and degradation of low density lipoprotein phospholipids. Proceedings of the National Academy of Sciences of the U.S.A. 1984; 81: 3883–3887
   PubMed Web of Science ®Google Scholar
• Lamb D. J., Wilkins G. H., Leake D. S. The oxida-tive modification of low density lipoprotein by human lymphocytes. Atherosclerosis 1992; 92: 187–192
   PubMed Web of Science ®Google Scholar
• Braesen J. H., Beisiegel U., Niendorf A. Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL rabbits. Virchow Archives 1995; 426: 179–188
   PubMed Web of Science ®Google Scholar
• Jessup W., Rankin S. M., De Whalley C.V., Hoult J. R.S., Scott J., Leake D. S. α-tocopherol consumption during low-density-lipoprotein oxidation. Biochemical Journal 1990; 265: 399–405
   PubMed Web of Science ®Google Scholar
• Zhang H., Basra H. J.K., Steinbrecher U. P. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. Journal of Lipid Research 1990; 31: 1361–1369
   PubMed Web of Science ®Google Scholar
• Lenz M. L., Hughes H., Mitchell J., Via D. P., Guyton J. R., Taylor A. A., Gotto A.M., Jr, Smith C. V. Lipid hydroperoxy and hydroxy derivatives in copper catalysed oxidation of low density lipoprotein. Journal of Lipid Research 1990; 31: 1043–1049
   PubMed Web of Science ®Google Scholar
• Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochemical Journal 1992; 286: 901–905
   PubMed Web of Science ®Google Scholar
• Clare K., Hardwick S. J., Carpenter K. L.H., Weeratunge N., Mitchinson M. J. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 1995; 118: 67–75
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxida-tive modification of LDL. Free Radicals in Biology and Medicine 1992; 13: 341–390
   PubMed Web of Science ®Google Scholar
• Darley-Usmar V. M., Severn A., O'Leary V.J., Rogers M. Treatment of macrophages with oxidised low-density lipoprotein increases their intra-cellular glutathione content. Biochemical Journal 1991; 278: 429–434
   PubMed Web of Science ®Google Scholar
• Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. Journal of Lipid Research 1991; 32: 1325–1332
   PubMed Web of Science ®Google Scholar
• Parthasarathy S. Evidence for an additional intra-cellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Journal of Clinical Investigation 1992; 89: 1618–1621
   PubMed Web of Science ®Google Scholar